Bootz F, Franzen A
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde, Universitätsklinikum Bonn, Venusberg-Campus 1, Gebäude 03, 53127, Bonn, Deutschland.
HNO. 2020 Sep;68(9):657-661. doi: 10.1007/s00106-020-00901-5.
Surgical therapy, regardless of the procedure, remains of great importance for today's treatment of oropharyngeal carcinomas, despite advances in radiation and immunotherapy. The individual treatment plan should be defined in discussion with the patient and in an interdisciplinary tumor conference, taking into account the likelihood of achieving of tumor-free resection margins and an acceptable postoperative quality of life. With regard to conventional and possibly also open surgical procedures, a good overview of the surgical site-particularly in the case of more extensive carcinomas and challenging patient anatomy-and simplified reconstructability of the defect region are decisive aspects. Endoscopically, microsurgically, or even robot-assisted minimally invasive procedures have the advantage of precise and gentle removal of tumor tissue with improved maintenance of function. Overall, selection of the appropriate surgical procedure remains an individual decision based on tumor size, the facilities at the tumor center, and the surgeon's experience. The extent of surgical intervention, also with regard to simultaneous neck dissection, depends on tumor stage. In the case of oropharyngeal carcinomas, there will be an increasing distinction between human papillomavirus (HPV)-negative and HPV-positive tumors in the future; however, the therapeutic strategy is currently identical. Upcoming clinical trials will show whether treatment de-escalation is appropriate depending on HPV infection status.
尽管放射治疗和免疫治疗取得了进展,但手术治疗,无论采用何种术式,对于当今口咽癌的治疗仍然至关重要。个体治疗方案应在与患者讨论并在多学科肿瘤会议中确定,同时要考虑实现无瘤切缘的可能性以及可接受的术后生活质量。对于传统的以及可能的开放手术,对手术部位有良好的视野——特别是在癌肿范围更广且患者解剖结构具有挑战性的情况下——以及缺损区域的简化可重建性是决定性因素。在内镜、显微手术甚至机器人辅助的微创手术中,具有精确且轻柔地切除肿瘤组织并改善功能维持的优势。总体而言,选择合适的手术方式仍然是基于肿瘤大小、肿瘤中心的设备以及外科医生经验的个体化决策。手术干预的范围,包括同期颈部清扫,取决于肿瘤分期。对于口咽癌,未来人乳头瘤病毒(HPV)阴性和HPV阳性肿瘤之间的区别将会越来越明显;然而,目前的治疗策略是相同的。即将开展的临床试验将表明根据HPV感染状态进行治疗降阶梯是否合适。